What is Diagnos-Techs?
Founded in 1987, Diagnos-Techs has carved a niche in healthcare by specializing in non-invasive testing options for providers and patients. The company initially focused on saliva testing for cortisol and has since broadened its portfolio to include a comprehensive range of saliva and stool test panels for hormones, food sensitivities, and gastrointestinal health. Leveraging advanced technology and a team of scientific experts, Diagnos-Techs is committed to delivering accurate, rapid, and high-quality diagnostic results, positioning itself as a key partner for healthcare providers seeking innovative solutions.
How much funding has Diagnos-Techs raised?
Diagnos-Techs has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Diagnos-Techs
PPP
Public-Private Partnership
What's next for Diagnos-Techs?
The recent large-scale, late-stage funding, characterized as a major strategic investment, signals Diagnos-Techs' readiness for accelerated growth and market expansion. This capital is likely to fuel further development of its diagnostic platforms, enhance operational capabilities, and potentially broaden its service offerings. The company's trajectory suggests a focus on solidifying its leadership in the non-invasive testing market and exploring new avenues for clinical application and strategic partnerships.
See full Diagnos-Techs company page
